NASDAQ:CLSN - Celsion Stock Price, Forecast & News

Celsion trades on the NASDAQ under the ticker symbol "CLSN."

Celsion's stock reverse split on the morning of Tuesday, May 30th 2017. The 1-14 reverse split was announced on Friday, May 26th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 26th 2017. An investor that had 100 shares of Celsion stock prior to the reverse split would have 7 shares after the split.

Celsion Co. (NASDAQ:CLSN) released its earnings results on Friday, November, 15th. The biotechnology company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.30) by $0.05. The biotechnology company earned $0.13 million during the quarter, compared to analyst estimates of $0.13 million. Celsion had a negative net margin of 1,653.20% and a negative return on equity of 57.46%. View Celsion's Earnings History.

Celsion is scheduled to release their next quarterly earnings announcement on Friday, April 3rd 2020. View Earnings Estimates for Celsion.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Celsion in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Celsion.

News headlines about CLSN stock have trended very negative this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Celsion earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave news headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Celsion.

Some companies that are related to Celsion include Cyclerion Therapeutics (CYCN), Clearside Biomedical (CLSD), Corvus Pharmaceuticals (CRVS), ESSA Pharma (EPIX), CannTrust (CTST), Savara (SVRA), REDHILL BIOPHAR/S (RDHL), Menlo Therapeutics (MNLO), IMMUTEP LTD/S (IMMP), Monopar Therapeutics (MNPR), Otonomy (OTIC), Trillium Therapeutics (TRIL), Trevi Therapeutics (TRVI), Aquestive Therapeutics (AQST) and Eton Pharmaceuticals (ETON).

Based on aggregate information from My MarketBeat watchlists, some companies that other Celsion investors own include Agenus (AGEN), Inovio Pharmaceuticals (INO), Rexahn Pharmaceuticals (REXN), Amarin (AMRN), Synergy Pharmaceuticals (SGYP), NovaBay Pharmaceuticals (NBY), Gilead Sciences (GILD), Nektar Therapeutics (NKTR), Novavax (NVAX) and Bausch Health Companies (BHC).

Celsion's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (0.35%). Company insiders that own Celsion stock include Alberto R Martinez Jr, Frederick J Fritz, Jeffrey Wayne Church, Michael H Tardugno and Robert W Hooper. View Institutional Ownership Trends for Celsion.

CLSN stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. Company insiders that have bought Celsion stock in the last two years include Alberto R Martinez Jr, Frederick J Fritz, Jeffrey Wayne Church, Michael H Tardugno and Robert W Hooper. View Insider Buying and Selling for Celsion.

Shares of CLSN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CLSN stock can currently be purchased for approximately $1.16.

Celsion has a market capitalization of $26.40 million and generates $500,000.00 in revenue each year. The biotechnology company earns $-11,880,000.00 in net income (profit) each year or ($0.68) on an earnings per share basis. Celsion employs 29 workers across the globe.View Additional Information About Celsion.

The official website for Celsion is http://www.celsion.com/.

Celsion's mailing address is 997 LENOX DRIVE SUITE 100, LAWRENCEVILLE NJ, 08648. The biotechnology company can be reached via phone at 609-896-9100 or via email at [email protected]